Literature DB >> 3749806

Endoscopic sclerotherapy of esophageal varices in an experimental animal model. A histomorphologic study.

L S Jensen, H Dybdahl, C Juhl, T H Nielsen.   

Abstract

Endoscopic sclerotherapy with Aethoxysclerol 2% was carried out in rabbits with esophageal varices. Nineteen animals were injected paravenously, and 17 were injected intravenously. The animals were killed between 1 h and 4 weeks after injection for histologic examination of the esophagus. None of the animals showed an acute total occlusive thrombosis of the large vessels, whereas edema and later fibrosis compressed the varices in the paravenously injected animals. After 4 weeks an almost complete repair with patent varices was observed in the intravenously treated group, whereas the varices in the paravenously injected group either had shrunk totally or were surrounded by a dense envelope of connective tissue. The study suggests that paravenous treatment of esophageal varices provides a higher degree of efficacy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749806     DOI: 10.3109/00365528609011108

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Endoscopic sclerotherapy in porcine esophagus changes luminal cross-sectional area and wall distensibility dose- and time-dependently.

Authors:  J A Petersen; C Djurhuus; J Koff; L Vinter-Jensen; H Gregersen
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

2.  Changes in oesophageal wall biomechanics after portal vein banding and variceal sclerotherapy measured by a new technique. An experimental study in rabbits.

Authors:  H Gregersen; L S Jensen; J C Djurhuus
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

3.  Major predictors and management of small-bowel angioectasia.

Authors:  Atsushi Igawa; Shiro Oka; Shinji Tanaka; Sayoko Kunihara; Makoto Nakano; Taiki Aoyama; Kazuaki Chayama
Journal:  BMC Gastroenterol       Date:  2015-08-25       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.